Toripalimab Plus Bevacizumab as First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research Jul, 2024 | Pubmed ID: 38687583